Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Lonza announced the completion of a laboratory expansion at its active pharmaceutical ingredients (API) manufacturing site at Nansha, China. The expansion focused on extending the capabilities and capacity of development laboratories and kilogram-...
read more
Wednesday, December 02, 2020
Lonza has announced additional investments in its oral drug product development and manufacturing capabilities at its Tampa, Florida site.
read more
Lonza announced an expansion of its highly potent API (HPAPI) capacity for the specific support of antibody drug conjugate (ADC) payload manufacturing.
read more
Tuesday, October 09, 2018
Lonza announced an expansion of its highly potent API capacity for the specific support of antibody drug conjugate payload manufacturing.
read more
Monday, December 05, 2022
Lonza announced the start of new mid-scale manufacturing assets at its API manufacturing center in Nansha, China.
read more
Monday, September 16, 2019
Mallinckrodt has entered into a definitive agreement to sell its wholly owned subsidiary BioVectra to an affiliate of H.I.G. Capital for approximately $250 million.
read more
Marken announced the acquisition of Touchdown International a privately held specialty logistics company in Taiwan, for an undisclosed sum.
read more
Med Opportunity Partners, LLC (“MEDOP”), a Greenwich CT-based private equity firm focused exclusively on the health care sector, announced today its acquisition of Ferro Pfanstiehl Laboratories, Inc., a global leader in cGMP carbohydrates and Active ...
read more
Tuesday, October 03, 2017
Medicure announced it has sold its interests in Apicore to an arm's length, pharmaceutical company.
read more
Thursday, September 06, 2018
WuXi AppTec congratulates its partner Hutchison MediPharma on receiving approval of Fruquintinib capsules (Elunate) for metastatic colorectal cancer from the NMPA.
read more
Thursday, January 02, 2020
MediWound announced the signing of a distribution agreement granting Balance Medical the exclusive rights to market and distribute NexoBrid® in Australia, New Zealand and Singapore for the treatment of severe burns.
read more
Wednesday, August 26, 2020
MediWound and Vericel announced the BARDA has accepted the first shipment of NexoBrid
read more
Friday, September 13, 2019
Meitheal announced the launch of the Company’s eight presentations of heparin sodium injection, USP in the US.
read more
Friday, February 28, 2020
Merck KGaA, Darmstadt, Germany and AMCM, Starnberg, Germany, announced a cooperation agreement on the 3D printing of tablets.
read more
Wednesday, January 15, 2020
Mereo BioPharma announced a global license agreement for the development and commercialization of navicixizumab.
read more